Immunocellular(美國)

Immunocellular

美國ImmunoCellularTherapeuticswww.imuc.comIMUC是一家總部位于洛杉磯的臨床階段公司，致力于開發(fā)免疫療法來治療腦癌和其它癌癥。該公司的先導(dǎo)候選產(chǎn)品ICT-107最近進入II期試驗，ICT-107是一種基于樹突狀細胞的疫苗，該疫苗以多個腫瘤相關(guān)抗原為靶向，用于治療新診斷出的膠質(zhì)母細胞瘤。Ourmissionistoimprovecancertreatmentan ddiagnosisthroughthediscoveryanddevelopmentofnewimmune-basedproducts.Designedtoharnessbotharmsofthenativeimmunesystem,ourpipelineincludesbothactiveimmunotherapiesandpatentedmonoclonalantibodies(mABs).Ouractiveimmunotherapiestargetnotonlyregulartumorcells,butalsothecancerstemcellsbelievedtocausecancergrowthandrecurrence.Ourmostadvancedclinicalprogramsareinglioblastomamultiforme(GBM),butourtechnologieshavepotentialapplicationsinmanycancerswithhighunmetmedicalneed,includingpancreatic,ovarian,colon,small-celllung,andmultiplemyeloma.OurleadproductcandidateisICT-107,apersonalized,dendriticcell-basedvaccineforthetreatmentofGBM.Weintendtoinitiate